TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27470500

Group type: EXPERIMENTAL
Intervention: School-based humanistic counselling (SBHC)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 64
Study: 25879932

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT) delivered by psychologists with usual care
Number of subjects: 246

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 246
Study: 23927194

Group type: EXPERIMENTAL
Intervention: 20 kHz ultrasound for 15 min
Number of subjects: 20

Group type: COMPARATOR
Intervention: 20 kHz ultrasound at 100 mW/cm(2)
Number of subjects: 20
Study: 20569223

Group type: EXPERIMENTAL
Intervention: Intravenous sodium valproate, loading dose of 900-1200 mg
Number of subjects: 36
Study: 19159881

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 17383335

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 14963702

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) 0.3 mg/kg per day for 3 days + 2 g/kg IVIG over 4 to 5 days
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group: 2 g/kg IVIG over 4 to 5 days + higher dose acetylsalicylic acid
Number of subjects: 46
Study: 11588947

Group type: EXPERIMENTAL
Intervention: 0.05 mg transdermal estradiol twice weekly
Number of subjects: 159

Group type: COMPARATOR
Intervention: 0.625 mg oral conjugated estrogen daily with 2.5 mg oral medroxyprogesterone acetate daily
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Transdermal therapy
Number of subjects: 159

Group type: COMPARATOR
Intervention: Oral treatment
Number of subjects: 159
Study: 9973671

Group type: EXPERIMENTAL
Intervention: Brisk walking intervention (20.4 +/- 3.9 min/day for 1 year)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (bb genotype)
Number of subjects: 69
Study: 7798545

Group type: EXPERIMENTAL
Intervention: Azelastine 0.1% (1 spray [0.12 mg] per nostril every 12 hours, 2 sprays per nostril every 12 hours, or 2 sprays per nostril once daily)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine maleate (12 mg twice daily)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Placebo (twice daily)
Number of subjects: 264
Study: 2647645

Group type: EXPERIMENTAL
Intervention: reserpine, prazosin, indapamide, atenolol (separately or in combination)
Number of subjects: 80

Group type: COMPARATOR
Intervention: prazosin
Number of subjects: 80
Study: 825133

Group type: EXPERIMENTAL
Intervention: Methaqualone hydrochloride (400 mg)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Methaqualone (20 and 30 mg/kg body weight) in monkeys
Number of subjects: 1
Study: 31403168

Group type: EXPERIMENTAL
Intervention: Cognitive and behavioral therapy for insomnia (CBT-i)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 145
Study: 29095305

Group type: EXPERIMENTAL
Intervention: Direct intramuscular injection of MSCs (1*10 cells in 1 mL of 0.9% saline)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo-controlled group (1 mL of 0.9% saline)
Number of subjects: 120
Study: 26465872

Group type: EXPERIMENTAL
Intervention: Statins + Amlodipine + Renin-Angiotensin-Aldosterone System Inhibitors (Benazepril or Losartan)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amlodipine + Renin-Angiotensin-Aldosterone System Inhibitors (Benazepril or Losartan) without Statins
Number of subjects: 0
Study: 23622070

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Routine pediatric care + OMT
Number of subjects: 110

Group type: COMPARATOR
Intervention: Routine pediatric care
Number of subjects: 110
Study: 21786539

Group type: EXPERIMENTAL
Intervention: High-intensity PRI training
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-intensity PRI training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional training
Number of subjects: 30
Study: 19190515

Group type: EXPERIMENTAL
Intervention: Investigational arm (first-line chemotherapy)
Number of subjects: 23457

Group type: COMPARATOR
Intervention: Reference arm (first-line chemotherapy)
Number of subjects: 23457
Study: 16765851

Group type: EXPERIMENTAL
Intervention: Johrei healing method
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control resting condition (10 min without Johrei)
Number of subjects: 33
Study: 12677732

Group type: EXPERIMENTAL
Intervention: Taste strips impregnated with different taste solutions (four concentrations each for sweet, sour, salty, and bitter)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Taste strips
Number of subjects: 69
Study: 11130155

Group type: EXPERIMENTAL
Intervention: On-campus bar
Number of subjects: 221

Group type: COMPARATOR
Intervention: Laboratory
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Just enough to begin to feel intoxicated
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Too much to drink
Number of subjects: 221
Study: 9268956

Group type: EXPERIMENTAL
Intervention: 20 mg.kg-1 dose of powdered aspirin
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (water and Kool-Aid mixture without aspirin)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Maximal cycle ergometry test
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 8-s cycling bouts at various power outputs (100, 150, 200, and 250 W)
Number of subjects: 19
Study: 1414219

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OXC) with Erythromycin (ERY)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Oxcarbazepine (OXC) without Erythromycin (ERY)
Number of subjects: 8
Study: 3973293

Group type: EXPERIMENTAL
Intervention: Two-dimensional echocardiography
Number of subjects: 125
Study: 31693128

Group type: EXPERIMENTAL
Intervention: Mailed HPV self-sampling kit
Number of subjects: 19851

Group type: COMPARATOR
Intervention: Usual care (annual patient reminders and ad hoc outreach)
Number of subjects: 19851
Study: 29377984

Group type: EXPERIMENTAL
Intervention: Inter-lead electrical delay (IED) ≥100 ms
Number of subjects: 160

Group type: COMPARATOR
Intervention: Inter-lead electrical delay (IED) <100 ms
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: IED categorized by tertiles
Number of subjects: 160
Study: 27898699

Group type: EXPERIMENTAL
Intervention: Extended 5-month Seasonal Malaria Chemoprevention (SMC) programme
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Future delivery of SMC by trained community health workers (CHWs)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Caregivers' physical access to SMC medication
Number of subjects: 21
Study: 24668314

Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy (NIRS)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Vascular occlusion testing (VOT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Brief Pain Inventory (BPI) and Disability of the Arm, Shoulder and Hand (DASH) questionnaires
Number of subjects: 10
Study: 22734373

Group type: EXPERIMENTAL
Intervention: Multivariate acupuncture of chronomedicine (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional acupuncture (group B)
Number of subjects: 50
Study: 20128827

Group type: EXPERIMENTAL
Intervention: Implant stability quotient (ISQ) measured in buccolingual direction
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Implant stability quotient (ISQ) measured in mesiodistal direction
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Higher ISQ values
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Lower ISQ values
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: ISQ variation groups (variation of 3 or more vs <3)
Number of subjects: 53
Study: 18387880

Group type: EXPERIMENTAL
Intervention: Educational PowerPoint presentation for employees, minor environmental acoustical alterations, use of a Quest 261 Sound Detector/Controller for behavioral modification
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study: 11665796

Group type: EXPERIMENTAL
Intervention: 800,000 units of intravenous monteplase followed by rescue PTCA
Number of subjects: 164

Group type: COMPARATOR
Intervention: Primary percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 164
Study: 9628067

Group type: EXPERIMENTAL
Intervention: Interleukin-2 (IL-2) administered subcutaneously at a dosage of 9,000,000 U.I. b.i.d. for three days before surgery
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 8166943

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg daily from mean gestational age of 17.7 weeks
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo from mean gestational age of 18 weeks
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg daily
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 3063048

Group type: EXPERIMENTAL
Intervention: Epidural clonidine 3 micrograms/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Epidural 0.9% saline (control)
Number of subjects: 20
Study: 30998400

Group type: EXPERIMENTAL
Intervention: Text messaging intervention (6 messages/week for 6 months)
Number of subjects: 822

Group type: COMPARATOR
Intervention: Control group (usual care + 2 thank you messages/month)
Number of subjects: 822

Group type: EXPERIMENTAL
Intervention: Text messaging intervention
Number of subjects: 822
Study: 28337880

Group type: EXPERIMENTAL
Intervention: Etomidate anesthesia
Number of subjects: 120

Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 120
Study: 25539349

Group type: EXPERIMENTAL
Intervention: AlloDerm
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: DermaMatrix
Number of subjects: 128
Study: 23747824

Group type: EXPERIMENTAL
Intervention: Clearfil Tri-S Bond (C3S; Kuraray)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: G-Bond (GB; GC)
Number of subjects: 30
Study: 22140531

Group type: EXPERIMENTAL
Intervention: Education intervention for GPs and care facility staff
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Education intervention for GPs and care facility staff (post hoc analysis)
Number of subjects: 351
Study: 19768649

Group type: EXPERIMENTAL
Intervention: Fosfomycin (3 g single dose)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate (7-day regimen)
Number of subjects: 109
Study: 17053340

Group type: EXPERIMENTAL
Intervention: Self-exposure therapy (4 weeks)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Waiting-list control (3 months)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Matched control group (month 0)
Number of subjects: 10
Study: 12721944

Group type: EXPERIMENTAL
Intervention: PCV7
Number of subjects: 0

Group type: COMPARATOR
Intervention: PPV23
Number of subjects: 0
Study: 10719136

Group type: EXPERIMENTAL
Intervention: Two‐session psychosocial intervention
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 41
Study: 9332921

Group type: EXPERIMENTAL
Intervention: Diltiazem (0.1 mg/kg per h)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Nitroglycerin (1 microgram/kg per min)
Number of subjects: 71
Study: 8458248

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (CFX) plus amikacin (single daily doses)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (CFX) plus amikacin (divided in three doses)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Ceftazidime plus amikacin
Number of subjects: 144
Study: 31999478

Group type: EXPERIMENTAL
Intervention: Faster insulin aspart
Number of subjects: 13

Group type: COMPARATOR
Intervention: Standard insulin aspart
Number of subjects: 13
Study: 30328674

Group type: EXPERIMENTAL
Intervention: Intensity-modulated proton therapy (IMPT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Volumetric-modulated arc therapy (VMAT)
Number of subjects: 24
Study: 28605557

Group type: EXPERIMENTAL
Intervention: Intensive management (target SBP < 140 mm Hg)
Number of subjects: 3233

Group type: COMPARATOR
Intervention: Contemporaneous guideline‐recommended management (target SBP < 180 mm Hg)
Number of subjects: 3233
Study: 26271344

Group type: EXPERIMENTAL
Intervention: 1 g metformin twice daily
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control (no metformin)
Number of subjects: 37
Study: 24391225

Group type: EXPERIMENTAL
Intervention: 810nm diode laser
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 0
Study: 21414151

Group type: EXPERIMENTAL
Intervention: Hyoid and laryngeal movement during swallowing
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Reduced anterior hyoid displacement and abnormal correlation patterns
Number of subjects: 28

Group type: COMPARATOR
Intervention: Cervical spine length
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Hyoid displacement
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Arytenoid displacement
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Positive hyoid‐laryngeal movement correlations
Number of subjects: 28
Study: 18696172

Group type: EXPERIMENTAL
Intervention: Relaxation Training (RT)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Written Emotional Disclosure (WED)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Neutral Writing Control
Number of subjects: 141
Study: 16861080

Group type: EXPERIMENTAL
Intervention: EndoREZ with master cones and passive application of accessory cones
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Application of Clearfil Liner Bond 2V before EndoREZ and gutta‐percha condensation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Warm vertical compaction with AH Plus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EndoREZ with 12 mm apical resection
Number of subjects: 0
Study: 12723823

Group type: EXPERIMENTAL
Intervention: Wearable continuous-read precision phase-change thermometer (WCPPT)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Glass-mercury thermometer (GMA)
Number of subjects: 29
Study: 11243631

Group type: EXPERIMENTAL
Intervention: Anti-CD3 antibodies (1 microg/ml)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phytohemagglutinin (10 microg/ml)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Staphylococcal enterotoxin A (0.1 microg/ml)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tuberculin purified protein derivative (10 microg/ml)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mixed lymphocyte reaction
Number of subjects: 0
Study: 9194443

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 40
Study: 8455962

Group type: EXPERIMENTAL
Intervention: Intra-articular ultrasonic stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intracutaneous electrical stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single oral dose of pethidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Electrical stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ultrasound stimulation
Number of subjects: 0
Study: 3513569

Group type: EXPERIMENTAL
Intervention: Folic acid (10 mg/day) for 4 months
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control medications
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Folic acid treatment
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cytogenetic studies with folic acid-free medium
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cytogenetic studies with antifolate (methotrexate)
Number of subjects: 10
Study: 30580261

Group type: EXPERIMENTAL
Intervention: Women in military camps
Number of subjects: 0
Study: 26581834

Group type: EXPERIMENTAL
Intervention: Moderate hypothermia (32°C)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normothermia (36°C)
Number of subjects: 20
Study: 24351527

Group type: COMPARATOR
Intervention: Standard VTE prophylaxis (5,000 U low‐molecular‐weight heparin daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: TEG‐guided prophylaxis (up to 10,000 U low‐molecular‐weight heparin daily)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 50
Study: 23167843

Group type: EXPERIMENTAL
Intervention: Nordic FLOX + cetuximab
Number of subjects: 535

Group type: COMPARATOR
Intervention: Nordic FLOX
Number of subjects: 535
Study: 20019197

Group type: EXPERIMENTAL
Intervention: Self-help physical activity program (including DSMEP, book 'Manpo-kei', handout, and pedometer)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Usual Diabetes Self-Management Education Program (DSMEP) only
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Self-help physical activity program
Number of subjects: 53
Study: 18657960

Group type: EXPERIMENTAL
Intervention: omalizumab
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: omalizumab (responders)
Number of subjects: 164
Study: 16176140

Group type: EXPERIMENTAL
Intervention: Cassia tora fiber supplement (2 g of soluble fiber, 200 mg of alpha-tocopherol, 500 mg of ascorbic acid, 300 mg of maltodextrin)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cassia tora fiber supplement
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (maltodextrin only)
Number of subjects: 15
Study: 12975221

Group type: EXPERIMENTAL
Intervention: Computerized decision-making support (CDS)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 107
Study: 10414119

Group type: EXPERIMENTAL
Intervention: Diode laser thermokeratoplasty (LTK) using a laser diode at 1.854 microns, 100 to 150 mW for 10 s, 8 coagulations on a single ring
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Diode laser thermokeratoplasty (LTK) using a laser diode at 1.87 microns, 100 to 150 mW for 10 s, 16 coagulations on a double ring
Number of subjects: 8
Study: 8690639

Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Combined treatment (Radiotherapy + Hyperthermia)
Number of subjects: 306
Study: 1859764

Group type: EXPERIMENTAL
Intervention: P6 acupressure
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 7120436

Group type: EXPERIMENTAL
Intervention: 20-hour long marital enrichment program (MEP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-treatment control conditions
Number of subjects: 0
Study: 30835887

Group type: EXPERIMENTAL
Intervention: Breastfeeding self‐management (BSM) intervention group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 60
Study: 28317507

Group type: EXPERIMENTAL
Intervention: eARM™ training program (hybrid online and in-person)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 334
Study: 27231170

Group type: COMPARATOR
Intervention: Oxygen intake 7 times/week (D group)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Oxygen intake 2 times/week (B group)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Oxygen intake 4 times/week (C group)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Oxygen intake 2 times/week (A group)
Number of subjects: 263
Study: 24759301

Group type: EXPERIMENTAL
Intervention: Low-calorie normal protein diet for 6 months
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 26
Study: 22662729

Group type: EXPERIMENTAL
Intervention: Telehealth intervention for self-care management; specific details on dosage and duration not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telecommunications technologies; specific details on dosage and duration not available.
Number of subjects: 0
Study: 20648564

Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy (DBT)
Number of subjects: 51
Study: 17204733

Group type: EXPERIMENTAL
Intervention: Couple Communication Program
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 67
Study: 16086615

Group type: EXPERIMENTAL
Intervention: Atypical features based on the 30-item Inventory of Depressive Symptomatology-Clinician Rating (IDS-C30)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Demographic and clinical parameters
Number of subjects: 1500
Study: 12135250

Group type: EXPERIMENTAL
Intervention: IAS pacing in AAIR mode plus antiarrhythmic drugs
Number of subjects: 29

Group type: COMPARATOR
Intervention: IAS pacing in AAIR mode without antiarrhythmic drugs
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: IAS pacing in AAT mode
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control period (before pacemaker implantation, under antiarrhythmic treatment)
Number of subjects: 29

Group type: COMPARATOR
Intervention: AAIR pacing mode without antiarrhythmic drugs
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: AAIR pacing mode plus antiarrhythmics
Number of subjects: 29
Study: 10025887

Group type: EXPERIMENTAL
Intervention: E. coli L-asparaginase at 10,000 IU/m2 thrice weekly for nine doses
Number of subjects: 201

Group type: COMPARATOR
Intervention: Epidoxorubicin at 20 mg/m2 weekly for two doses
Number of subjects: 201
Study: 7862469

Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC) 15 to 20 micrograms/kg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo lollipop
Number of subjects: 48
Study: 2031199

Group type: EXPERIMENTAL
Intervention: Vindesin 3 mg/m2 plus epirubicin 100 mg/m2 plus cyclophosphamide 600 mg/m2 + lonidamine 600 mg/day orally
Number of subjects: 12

Group type: COMPARATOR
Intervention: Vindesin 3 mg/m2 plus epirubicin 100 mg/m2 plus cyclophosphamide 600 mg/m2
Number of subjects: 12
Study: 6284459

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 30439786

Group type: EXPERIMENTAL
Intervention: 2500 m sedentary (n = 11)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 2500 m active (n = 8)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 3000 m sedentary (n = 6)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 3000 m active (n = 12)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 3500 m sedentary (n = 6)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 3500 m active (n = 8)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 4300 m sedentary (n = 7)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 4300 m active (n = 8)
Number of subjects: 66
Study: 28333757

Group type: EXPERIMENTAL
Intervention: Vasopressin (0.03 U/min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Norepinephrine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vasopressin and Norepinephrine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cytokine levels
Number of subjects: 0
Study: 26399503

Group type: EXPERIMENTAL
Intervention: Kanyini GAP intervention
Number of subjects: 94